Lourdes Ortiz

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 297 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Faustino Torrico, Joaquím Gascón, Fabiana Barreira et al. · The Lancet Infectious Diseases · 2021 · 199 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform

María‐Jesús Pinazo, Jimy Pinto, Lourdes Ortiz et al. · PLoS neglected tropical diseases · 2017 · 71 citations · Full text

Veterinary Medicine, Health Policy, Infectious Diseases +17

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · Clinical Infectious Diseases · 2022 · 52 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +7

Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease

Rudy Parrado, Juan Carlos Ramı́rez, Anabelle de la Barra et al. · Antimicrobial Agents and Chemotherapy · 2018 · 51 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +17